Table 1 Clinical and pathological characteristics
From: E-cadherin expression in primary carcinomas of the breast and its distant metastases
Number of patients | 30 |
|---|---|
Median age (range) (years) | 53.9 (39–80) |
Pathologic stage at diagnosis [n (%)] | Â |
   Stage I | 3 (10) |
   Stage II | 13 (43.3) |
   Stage III | 6 (20) |
   Stage IV | 2 (6.7) |
Tumor size (range) (cm) | 2.7 (0.5–7) |
Histologic type [n (%)] | Â |
   Ductal | 22 (73) |
   Lobular | 8 (27) |
Histologic grade [n (%)] | Â |
   Grade 1 | 6 (20) |
   Grade 2 | 17 (57) |
   Grade 3 | 7 (23) |
Lymph node status [n (%)] | Â |
   Negative | 7 (28) |
   Positive | 18 (72) |
Estrogen receptor status [n (%)] | Â |
   Negative | 7 (27) |
   Positive | 19 (73) |
Progesterone receptor status [n (%)] | Â |
   Negative | 9 (36) |
   Positive | 16 (64) |
Median time to develop distant metastases (months) | Â |
   Ductal | 33 |
   Lobular | 74 |